Arecor Therapeutics Statistics
Total Valuation
AIM:AREC has a market cap or net worth of GBP 24.92 million. The enterprise value is 18.89 million.
| Market Cap | 24.92M |
| Enterprise Value | 18.89M |
Important Dates
The last earnings date was Monday, April 13, 2026.
| Earnings Date | Apr 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AIM:AREC has 37.76 million shares outstanding. The number of shares has decreased by -0.72% in one year.
| Current Share Class | 37.76M |
| Shares Outstanding | 37.76M |
| Shares Change (YoY) | -0.72% |
| Shares Change (QoQ) | +4.15% |
| Owned by Insiders (%) | 15.96% |
| Owned by Institutions (%) | 45.71% |
| Float | 21.26M |
Valuation Ratios
The trailing PE ratio is 23.51.
| PE Ratio | 23.51 |
| Forward PE | n/a |
| PS Ratio | 14.54 |
| PB Ratio | 3.86 |
| P/TBV Ratio | 3.87 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.47, with an EV/FCF ratio of -7.67.
| EV / Earnings | 28.44 |
| EV / Sales | 11.02 |
| EV / EBITDA | 16.47 |
| EV / EBIT | 20.27 |
| EV / FCF | -7.67 |
Financial Position
The company has a current ratio of 4.78, with a Debt / Equity ratio of 0.02.
| Current Ratio | 4.78 |
| Quick Ratio | 4.35 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.09 |
| Debt / FCF | -0.04 |
| Interest Coverage | 84.73 |
Financial Efficiency
Return on equity (ROE) is 15.79% and return on invested capital (ROIC) is 207.08%.
| Return on Equity (ROE) | 15.79% |
| Return on Assets (ROA) | 6.93% |
| Return on Invested Capital (ROIC) | 207.08% |
| Return on Capital Employed (ROCE) | 14.36% |
| Weighted Average Cost of Capital (WACC) | 3.15% |
| Revenue Per Employee | 38,955 |
| Profits Per Employee | 15,091 |
| Employee Count | 44 |
| Asset Turnover | 0.20 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, AIM:AREC has paid 62,000 in taxes.
| Income Tax | 62,000 |
| Effective Tax Rate | 6.24% |
Stock Price Statistics
The stock price has increased by +72.50% in the last 52 weeks. The beta is -0.20, so AIM:AREC's price volatility has been lower than the market average.
| Beta (5Y) | -0.20 |
| 52-Week Price Change | +72.50% |
| 50-Day Moving Average | 70.83 |
| 200-Day Moving Average | 71.09 |
| Relative Strength Index (RSI) | 38.98 |
| Average Volume (20 Days) | 13,720 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AIM:AREC had revenue of GBP 1.71 million and earned 664,000 in profits. Earnings per share was 0.02.
| Revenue | 1.71M |
| Gross Profit | 1.27M |
| Operating Income | 932,000 |
| Pretax Income | 994,000 |
| Net Income | 664,000 |
| EBITDA | 1.15M |
| EBIT | 932,000 |
| Earnings Per Share (EPS) | 0.02 |
Balance Sheet
The company has 6.13 million in cash and 98,000 in debt, with a net cash position of 6.03 million or 0.16 per share.
| Cash & Cash Equivalents | 6.13M |
| Total Debt | 98,000 |
| Net Cash | 6.03M |
| Net Cash Per Share | 0.16 |
| Equity (Book Value) | 6.45M |
| Book Value Per Share | 0.19 |
| Working Capital | 6.09M |
Cash Flow
In the last 12 months, operating cash flow was -2.36 million and capital expenditures -99,000, giving a free cash flow of -2.46 million.
| Operating Cash Flow | -2.36M |
| Capital Expenditures | -99,000 |
| Depreciation & Amortization | 215,000 |
| Net Borrowing | -88,000 |
| Free Cash Flow | -2.46M |
| FCF Per Share | -0.07 |
Margins
Gross margin is 73.86%, with operating and profit margins of 54.38% and 38.74%.
| Gross Margin | 73.86% |
| Operating Margin | 54.38% |
| Pretax Margin | 57.99% |
| Profit Margin | 38.74% |
| EBITDA Margin | 66.92% |
| EBIT Margin | 54.38% |
| FCF Margin | n/a |
Dividends & Yields
AIM:AREC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.72% |
| Shareholder Yield | 0.72% |
| Earnings Yield | 2.66% |
| FCF Yield | -9.88% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |